
- Pharmaceutical Technology\'s In the Lab eNewsletter-09-05-2018
- Volume 13
- Issue 9
Metrohm Acquires B&W Tek
The acquisition will increase Metrohm’s spectroscopy offerings and capabilities.
On July 27, 2018, Metrohm AG, a manufacturer of high-precision instruments for chemical analysis, announced that it acquired B&W Tek’s spectroscopy solution business, B&W Tek, as well as several subsidiaries. B&W Tek is a provider of Raman spectroscopy solutions as well as laser-induced breakdown spectroscopy technology, near-infrared spectroscopy, and ultraviolet–visible spectroscopy/ultraviolet–visible spectrometers and solutions.
According to Metrohm, the acquisition contributes to the development of the company’s Raman product line as well as the company’s overall growth strategy. Financial details of the transaction were not disclosed.
B&W Tek will continue to operate under its own brand with its own sales and service organization for the time being to avoid any business disruption. After this transition period, B&W Tek will be gradually integrated into the Metrohm organization.
Source:
Articles in this issue
about 7 years ago
Glycan Analysis: Challenges and Benefits of Outsourcingabout 7 years ago
Assessing the E&L Risk in Biologic Drugsabout 7 years ago
Solutions and Solvents Improve Analytical Instrument Performanceabout 7 years ago
New Mass Spec Software Simplifies Data Analysisabout 7 years ago
Sotera Health’s Nelson Labs Acquires Gibraltar Laboratoriesabout 7 years ago
Enhanced Analysis with New Triple Quadrupole Mass Spectrometerabout 7 years ago
New EBSD Detector Features Advanced Sensors and OpticsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





